Department of Cardiac Sciences, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Chest Diseases Hospital, Kuwait.
Glob Heart. 2024 Apr 25;19(1):40. doi: 10.5334/gh.1321. eCollection 2024.
Previous registries have shown a younger average age at presentation with cardiovascular diseases in the Middle East (ME), but no study has examined atrioventricular block (AVB). Moreover, these comparisons are confounded by younger populations in the ME. We sought to describe the average age at presentation with AVB in ME and quantify the effect of being from ME, adjusted for the overall younger population.
This was a retrospective analysis of PANORAMA registries, which collected data on patients who underwent cardiac rhythm device placement worldwide. Countries with a median population age of ≤30 were considered 'young countries'. Multivariate linear regression was performed to assess the effect of being from ME, adjusted for being from a 'young country', on age at presentation with AVB.
The study included 5,259 AVB patients, with 640 (8.2%) from the ME. Mean age at presentation was seven years younger in ME than in other regions (62.9 ± 17.8 vs. 70 ± 14.1, P < 0.001). Being from a 'young country' was associated with 5.6 years younger age at presentation (95%CI -6.5--4.6), whereas being from ME was associated with 3.1 years younger age at presentation (95%CI -4.5--1.8), (P < 0.001 for both).
The average age at presentation with AVB in the ME is seven years younger than in other regions. While this is mostly driven by the overall younger population, being from the ME appears to be independently associated with younger age. Determinants of the earlier presentation in ME need to be assessed, and care should be taken when applying international recommendations.
先前的注册研究表明,中东(ME)心血管疾病的平均发病年龄较年轻,但尚无研究检查房室传导阻滞(AVB)。此外,这些比较受到 ME 中较年轻人群的影响。我们旨在描述 ME 中 AVB 的平均发病年龄,并量化来自 ME 的影响,同时调整整体较年轻的人群。
这是对 PANORAMA 注册研究的回顾性分析,该研究收集了全球接受心脏节律装置植入的患者数据。中位数年龄≤30 岁的国家被认为是“年轻国家”。采用多元线性回归来评估来自 ME 的影响,同时调整来自“年轻国家”的影响,以评估其对 AVB 发病年龄的影响。
该研究纳入了 5259 例 AVB 患者,其中 640 例(8.2%)来自 ME。与其他地区相比,ME 患者的平均发病年龄年轻了 7 岁(62.9±17.8 岁 vs. 70±14.1 岁,P<0.001)。来自“年轻国家”与发病年龄年轻 5.6 岁相关(95%CI-6.5-4.6),而来自 ME 与发病年龄年轻 3.1 岁相关(95%CI-4.5-1.8)(两者均 P<0.001)。
与其他地区相比,ME 中 AVB 的平均发病年龄年轻了 7 岁。虽然这主要是由整体较年轻的人群所驱动,但来自 ME 的影响似乎与年轻的发病年龄独立相关。需要评估 ME 中更早出现的决定因素,并且在应用国际建议时应谨慎。